We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Designer “Bath Salts” Provoke Acute Stimulant Overdose

By HospiMedica International staff writers
Posted on 30 Jan 2012
Over the counter psychoactive “bath salts” (PABS) that contain cardiovascular (CV) and central nervous system (CNS) stimulants are the latest designer drugs sending patients to the emergency department (ED). More...


Unlike traditional bath salts that are added to bath water for a relaxing soak, these drugs, which can also be ingested, inhaled, or injected, contain CNS stimulants such as 4-methylmethcarhinone (mephedrone) and 3,4 –methylenedioxypyrovalerone (MDPV). Dozens of patients have presented at emergency departments (EDs) with clinical findings consistent with stimulant overdose, many sick enough to require admission, and at least one death on arrival (DOA) has been attributed to MDPV. The most common signs and symptoms were agitation, tachycardia, and delusions or hallucinations.

In one observational study conducted during 2011 by the Children’s Hospital of Michigan Regional Poison Control Center (MPCC; Detroit, USA) of 35 patients presenting to EDs after ingestion, inhalation, or injection of PABS, 32 (91%) had neurologic symptoms, 27 (77%) had CV symptoms, and 17 (49%) had psychological symptoms. Of the 35 patients, 21(63%) had injected the bath salts, 9 (26%) snorted the drug, and 4 (11%) had ingested it. The route of ingestion for five patients, including the one DOA, was unknown.

The principal ingredients in PABS are known as synthetic cathinones, phenylalkylamines derivatives of cathinone, a naturally occurring beta-ketone amphetamine analogue found in the leaves of the Catha edulis plant. Those that are being used as drugs of abuse include butylone, dimethylcathinone, ethcathinone, ethylone, mephedrone, methedrone, MDPV, methylone, and pyrovalerone, and are often termed bk-amphetamines for their beta-ketone moiety.

They may possess both amphetamine-like properties and the ability to modulate serotonin, causing distinct psychoactive effects. Desired effects reported by users of synthetic cathinones include increased energy, empathy, openness, and increased libido. Exposure to and use of synthetic cathinones are becoming increasingly popular despite a lack of scientific research and understanding of the potential harms of these substances. The clinical similarities to amphetamines are predictable, based on the chemical structure of this class of agents. A comprehensive review of the toxicology of bath salts was published early online on November 23, 2011, in the Journal of Medical Toxicology.

Despite growing efforts to ban these products through legislation, PABS often skirt substance-control laws and are readily available at low cost. These products are easily obtained over the Internet under such names as Ivory Wave or Vanilla Sky, and are marketed as producing “a high similar to that obtained with illegal stimulants” such as methamphetamine. They are sometimes referred to as “legal cocaine” (but without causing the pronounced euphoria), as alertness enhancers, or as aphrodisiacs. The risk of overdose is high, since packages contain as much as 500 mg, and some labels suggest escalating the dose to more than 50 mg.

Related Links:

Children’s Hospital of Michigan Regional Poison Control Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.